Abstract

BackgroundDuring the COVID-19 pandemic, antibody testing was proposed by several countries as a surveillance tool to monitor the spread of the virus and potentially to ease restrictions. In the UK, antibody testing originally formed the third pillar of the UK Government's COVID-19 testing programme and was thought to offer hope that those with a positive antibody test result could return to normal life. However, at that time scientists and the public had little understanding of the longevity of COVID-19 antibodies, and whether they provided immunity to reinfection or transmission of the virus.ObjectiveThis paper explores the UK public's understanding of COVID-19 testing, perceived test accuracy, the meaning of a positive test result, willingness to adhere to restrictive measures in response to an antibody test result and how they expect other people to respond.MethodsOn-line synchronous focus groups were conducted in April/May 2020 during the first wave of the pandemic and the most stringent period of the COVID-19 restrictive measures. Data were analysed thematically.ResultsThere was confusion in responses as to whether those with a positive or negative test should return to work and which restrictive measures would apply to them or their household members. Participants raised concerns about the wider public response to positive antibody test results and the adverse behavioural effects. There were worries that antibody tests could create a divided society particularly if those with a positive test result were given greater freedoms or chose to disregard the restrictive measures.ConclusionShould these tests be offered more widely, information should be developed in consultation with the public to ensure clarity and address uncertainty about test results and subsequent behaviours.

Highlights

  • At the end of December 2019, the World Health Organization (WHO) was alerted to a cluster of unusual pneumonia cases in Wuhan, Hubei Province in China

  • In the first phase of the COVID-19 pandemic, antibody testing was proposed by several countries as a means of gathering data on the spread of the virus and/or, to inform strategies to ease restrictive measures, and test and trace programmes (Baraniuk 2020) to identify the source of clusters of infections (Normile 2020)

  • Martin – Group 1, 28, FT, Lives with Partner. This qualitative study highlights the confusion amongst some members of the UK public in the early stages of the pandemic about the different tests for COVID-19, worries over the uncertainties in the sci­ entific community regarding reinfection and transmission for those with a positive test, the meaning of positive and negative test results for future behaviour with regard to the restrictive measures and the po­ tential inequities these tests could create

Read more

Summary

Introduction

At the end of December 2019, the World Health Organization (WHO) was alerted to a cluster of unusual pneumonia cases in Wuhan, Hubei Province in China. In the first phase of the COVID-19 pandemic, antibody testing was proposed by several countries as a means of gathering data on the spread of the virus and/or, to inform strategies to ease restrictive measures, and test and trace programmes (Baraniuk 2020) to identify the source of clusters of infections (Normile 2020). In the case of this virus, at the time this study was conducted in April/May 2020, scientists and the public had little understanding of the longevity of antibodies, and whether they provided immunity to reinfection or transmission. At that time scientists and the public had little understanding of the longevity of COVID-19 antibodies, and whether they provided immunity to reinfection or transmission of the virus.

Objectives
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call